2 results
Approved WMOPending
To assess the long-term safety and tolerability of 35 mg and 70 mg RVT-101 in subjects with DLB
Approved WMORecruiting
Primary:- To test whether bevacizumab added to a backbone chemotherapy regimen (temozolomide or irinotecan-temozolomide or topotecan-temozolomide) demonstrates activity in children with relapsed or refractory neuroblastoma- To test whether the…